UNSPSC 85812032: Introduction of serum, toxoid and vaccine into nose, external approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of serum, toxoid and vaccine into nose, external approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E09X4Z

UNSPSC 85812032 Introduction of serum, toxoid and vaccine into nose, external approach is a Commodity code. State and local governments show little relevant recent activity under this code; the recent opportunities posted do not align with the nominal vaccination-administration scope. Inland Empire Health Plan's RFI for virtual urgent care services, DeKalb County's medical services RFP, and the Nevada Health Authority's PACE and RVAN solicitations address broader healthcare delivery, care coordination, and medical management work—not intranasal vaccine or toxoid administration. The code tier and scope mismatch suggests either administrative tagging inconsistency or a procurement category that does not currently drive active state and local demand.

The geographic spread of recent opportunities spans California, Georgia, and Nevada, with isolated activity in Florida, Arizona, Colorado, Illinois, and other states across behavioral health, occupational health, and medical direction contracting. No pattern of repeat solicitation under the vaccine-administration code emerges from the block; instead, opportunities cluster around adult mental health services, opioid-use-disorder treatment, emergency medical services staffing, and employee wellness platforms. The code itself does not appear to be a primary vehicle for state and local procurement at this time.